NAB1_RAT
ID NAB1_RAT Reviewed; 485 AA.
AC Q62722;
DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2000, sequence version 2.
DT 03-AUG-2022, entry version 139.
DE RecName: Full=NGFI-A-binding protein 1;
DE AltName: Full=EGR-1-binding protein 1;
GN Name=Nab1;
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Brain;
RX PubMed=7624335; DOI=10.1073/pnas.92.15.6873;
RA Russo M.W., Sevetson B.R., Milbrandt J.;
RT "Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated
RT transcription.";
RL Proc. Natl. Acad. Sci. U.S.A. 92:6873-6877(1995).
RN [2]
RP FUNCTION.
RX PubMed=9418898; DOI=10.1128/mcb.18.1.512;
RA Swirnoff A.H., Apel E.D., Svaren J., Sevetson B.R., Zimonjic D.B.,
RA Popescu N.C., Milbrandt J.;
RT "Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional
RT repression domain.";
RL Mol. Cell. Biol. 18:512-524(1998).
CC -!- FUNCTION: Acts as a transcriptional repressor for zinc finger
CC transcription factors EGR1 and EGR2. Also represses multiple types of
CC non-EGR1 activation domains (in vitro). {ECO:0000269|PubMed:9418898}.
CC -!- SUBUNIT: Homomultimers may associate with EGR1 bound to DNA.
CC -!- SUBCELLULAR LOCATION: Nucleus.
CC -!- DOMAIN: The NAB conserved domain 1 (NCD1) interacts with EGR1
CC inhibitory domain and mediates multimerization.
CC -!- DOMAIN: The NAB conserved domain 2 (NCD2) is necessary for
CC transcriptional repression.
CC -!- SIMILARITY: Belongs to the NAB family. {ECO:0000305}.
CC -!- SEQUENCE CAUTION:
CC Sequence=AAC52236.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U17253; AAC52236.1; ALT_INIT; mRNA.
DR PIR; I59402; I59402.
DR RefSeq; NP_074047.2; NM_022856.5.
DR RefSeq; XP_006244964.1; XM_006244902.3.
DR AlphaFoldDB; Q62722; -.
DR SMR; Q62722; -.
DR STRING; 10116.ENSRNOP00000017813; -.
DR iPTMnet; Q62722; -.
DR PhosphoSitePlus; Q62722; -.
DR PaxDb; Q62722; -.
DR PRIDE; Q62722; -.
DR Ensembl; ENSRNOT00000017813; ENSRNOP00000017813; ENSRNOG00000012959.
DR GeneID; 64824; -.
DR KEGG; rno:64824; -.
DR UCSC; RGD:70882; rat.
DR CTD; 4664; -.
DR RGD; 70882; Nab1.
DR eggNOG; KOG3835; Eukaryota.
DR GeneTree; ENSGT00390000006330; -.
DR HOGENOM; CLU_561344_0_0_1; -.
DR InParanoid; Q62722; -.
DR OMA; LCMRDTA; -.
DR OrthoDB; 1002244at2759; -.
DR PRO; PR:Q62722; -.
DR Proteomes; UP000002494; Chromosome 9.
DR Bgee; ENSRNOG00000012959; Expressed in liver and 20 other tissues.
DR Genevisible; Q62722; RN.
DR GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR GO; GO:0042552; P:myelination; ISO:RGD.
DR GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro.
DR GO; GO:0045682; P:regulation of epidermis development; ISO:RGD.
DR GO; GO:0006355; P:regulation of transcription, DNA-templated; ISO:RGD.
DR GO; GO:0014037; P:Schwann cell differentiation; ISO:RGD.
DR Gene3D; 1.20.120.2010; -; 1.
DR InterPro; IPR006986; Nab1_C.
DR InterPro; IPR006989; NAB_co-repressor_dom.
DR InterPro; IPR039040; NAB_fam.
DR InterPro; IPR006988; Nab_N.
DR InterPro; IPR038398; NCD2_sf.
DR PANTHER; PTHR12623; PTHR12623; 1.
DR Pfam; PF04902; Nab1; 1.
DR Pfam; PF04904; NCD1; 1.
DR Pfam; PF04905; NCD2; 1.
PE 2: Evidence at transcript level;
KW Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW Transcription; Transcription regulation; Ubl conjugation.
FT CHAIN 1..485
FT /note="NGFI-A-binding protein 1"
FT /id="PRO_0000077041"
FT REGION 4..82
FT /note="NCD1"
FT REGION 160..188
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 220..309
FT /note="NCD2"
FT REGION 391..422
FT /note="Necessary for nuclear localization"
FT REGION 398..431
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 160..175
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 171
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q61122"
FT MOD_RES 182
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q61122"
FT MOD_RES 327
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT MOD_RES 404
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q61122"
FT CROSSLNK 126
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 129
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 143
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 211
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 332
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO1); alternate"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 332
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 354
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 367
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 371
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 452
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 463
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 475
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 478
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO1); alternate"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
FT CROSSLNK 478
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:Q13506"
SQ SEQUENCE 485 AA; 54026 MW; D77B85B238204677 CRC64;
MATALPRTLG ELQLYRILQK ANLLSYFDAF IQQGGDDVQQ LCEAGEEEFL EIMALVGMAS
KPLHVRRLQK ALRDWVTNPG LFNQPLTSLP VSSIPIYKLP EGSPTWLGIS CNSYERSSSA
REPHLKVPKC AATTCVQSLG QGKSEVGSLA LQSVSESRLW QGHHTTESEH SLSPADLGSP
ASPKESSEAL DAAAALSVAE CVERMAPTLP KSDLNEVKEL LKNNKKLAKM IGHIFEMSDE
DPHKEEEIRK YSAIYGRFDS KRKDGKHLTL HELTVNEAAA QLCVKDNALL TRRDELFALA
RQVSREVTYK YTYRTTRLKC GERDELSPKR IKMEDGFPDF QESVPTLFQQ ARAKSEELAG
LSSQAEKGMA KQMELLCAQA GYERLQQERR LMAGLYRQSS GEQSPDGGLP SDGSDGQGER
PLNLRIPSVQ NRQPHHFVVD GELSRLYSNE VKSHSSESLG ILKDYPHSAF TLEKKVIKTE
PEDSR